Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in SAPHO syndrome with nail involvement
ChiCTR1900025941Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tofacitinib in SAPHO syndrome (SAPHO), sponsored by Peking Union Medical College. Primary endpoint: Nail Psoriasis Severity Index. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
03
Conditions
SAPHO syndrome (SAPHO)
Beyond the preview
Go deeper on ChiCTR1900025941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025941.